The Scientist

» drug development and immunology

Most Recent

image: MERS Help on the Horizon?

MERS Help on the Horizon?

By | July 1, 2015

New research finds that a treatment for Middle East respiratory syndrome can prevent and treat the disease in mice, while an experimental vaccine moves into human testing.

0 Comments

image: Brrrr-ying the Results

Brrrr-ying the Results

By | July 1, 2015

Holding laboratory mice at temperatures lower than those the animals prefer could be altering their physiology and skewing experimental results.

1 Comment

image: Diagnosing Ebola in 15 Minutes

Diagnosing Ebola in 15 Minutes

By | June 30, 2015

A new test that scans for the Ebola virus with just a fingerprick could be a practical diagnostic for use in West Africa.

0 Comments

image: Sex Differences in Pain Pathway

Sex Differences in Pain Pathway

By | June 29, 2015

Male and female mice utilize different immune cells to process pain, a study shows.

1 Comment

image: Organ-on-a-Chip Gets Big Pharma Boost

Organ-on-a-Chip Gets Big Pharma Boost

By | June 18, 2015

Johnson & Johnson agrees to use Emulate’s blood-clot device in three of its preclinical drug programs.

0 Comments

image: Neutralizing HIV

Neutralizing HIV

By | June 18, 2015

Engineered immunogens based on conserved patches of the virus’s envelope protein point to new strategies for vaccine design.

0 Comments

image: Drug for Low Sex Drive in Women?

Drug for Low Sex Drive in Women?

By | June 8, 2015

A federal advisory panel supports the US Food and Drug Administration’s approval of the first drug for female sexual dysfunction.

1 Comment

image: Brain Drain

Brain Drain

By | June 1, 2015

The brain contains lymphatic vessels similar to those found elsewhere in the body, a mouse study shows.

3 Comments

image: New Immunity

New Immunity

By | June 1, 2015

A scaffolding protein forms the hub of a newly identified immune pathway in plants.

0 Comments

image: Targeting Protein Domains with CRISPR

Targeting Protein Domains with CRISPR

By | May 13, 2015

Researchers use the genome-editing tool to mutate binding pockets and identify potential anti-cancer drug targets.

0 Comments

Popular Now

  1. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  2. How Plants Evolved Different Ways to Make Caffeine
  3. ESP on Trial
    Foundations ESP on Trial

    In the 1930s, parapsychologist Joseph Banks Rhine aimed to use scientific methods to confirm the existence of extrasensory perception, but faced criticisms of dubious analyses and irreproducible results.

  4. Another DNA Vaccine for Zika Shows Promise
RayBiotech